| Active Not Recruiting | Clinical Performance Evaluation of the QIAstat-Dx® cUTI Plus AMR Complicated Urinary Tract Infection | — | 2025-12-23 |
| Active Not Recruiting | Clinical Performance of QIAstat-Dx® Meningitis/Encephalitis (ME) Panel Plus Meningitis, Encephalitis Infection | — | 2025-04-03 |
| Terminated | Clinical Evaluation of the NeuMoDx SARS-CoV-2 Assay (COVID-19) SARS-CoV-2 Acute Respiratory Disease | — | 2024-02-06 |
| Recruiting | DHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit Metastatic Colorectal Cancer (mCRC) | N/A | 2023-12-22 |
| Completed | QIAstat-Dx® BCID Plus AMR Panels Clinical Performance Study Blood Disease | — | 2023-12-01 |
| Completed | QIAstat-Dx® Respiratory Panel Plus (RPP) Clinical Performance Study Respiratory Disease | — | 2023-02-23 |
| Completed | Clinical Performance Evaluation of the NeuMoDx™ EBV Quant Assay 2.0 in Immunocompromised Transplant Patients EBV Viremia | — | 2022-08-31 |
| Completed | QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study Meningitis/Encephalitis | — | 2022-05-04 |
| Completed | Clinical Performance Evaluation of the NeuMoDx™ FluA/FluB/RSV/Severe Acute Respiratory Syndrome-CoV-2 Assay Respiratory Disease | — | 2022-03-11 |
| Completed | Therascreen® KRAS RGQ PCR Kit Colo-rectal Cancer | N/A | 2022-01-07 |
| Completed | QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study 001 Meningitis/Encephalitis | — | 2021-10-08 |
| Completed | Clinical Performance of QIAstat-Dx® Gastrointestinal Panel 2 Gastrointestinal Infection | — | 2020-09-14 |
| Completed | Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit Non Small Cell Lung Cancer | — | 2020-04-02 |
| Withdrawn | QuantiFERON Access Clinical Performance Study Protocol Tuberculosis (TB) | — | 2020-04-01 |
| Completed | Clinical Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR Ki Non-small Cell Lung Cancer | N/A | 2020-03-13 |
| Completed | Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit Non-Small Cell Lung Cancer, Colorectal Cancer | N/A | 2019-07-01 |
| Terminated | Clinical Evaluation of the QuantiFERON CMV Assay CMV | — | 2018-11-15 |
| Completed | Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection Tuberculosis | — | 2015-10-27 |
| Terminated | Performance Comparison of QuantiFERON Monitor in Solid Organ Transplant Recipients Cell-mediated Immune Response | — | 2015-07-01 |
| Completed | Evaluation of the QuantiFERON-TB Test. Tuberculosis | — | 2015-02-02 |
| Completed | Evaluation of the QuantiFERON-TB Test. Tuberculosis | — | 2014-10-01 |
| Completed | Evaluation of the QuantiFERON-TB Test. Tuberculosis | — | 2014-05-27 |
| Terminated | Clinical Evaluation of the AmniSure ROM Test Rupture of Fetal Membranes | — | 2013-08-01 |
| Terminated | Evaluation of a Blood Test to Measure Immune Function in HIV Positive People Compared With HIV Negative People HIV Positive | — | 2013-07-01 |
| Completed | Collection and Testing of Respiratory Samples QIAGEN ResPlex II Advanced Panel, Influenza A, Respiratory Syncytial Virus Infections | — | 2011-02-01 |
| Completed | Collection and Extraction of Respiratory Specimens Influenza | — | 2010-03-01 |
| Completed | Evaluation of the Artus® CMV PCR Test Cytomegalovirus Infections | — | 2009-12-01 |